-
Study aim
-
Effect of 940 nm LLLT on TMD treatment
-
Design
-
Clinical trial with control group, parallel groups, three blinded, randomized, phase 2 on 34 patients. The Rand function of Excel 2010 software was used for randomization.
-
Settings and conduct
-
In this three-blind randomized clinical trial, 34 patients with symptoms of TMD will be randomly divided into intervention and placebo groups (n = 17). In the intervention group, 940 nm laser by Epic X biolase laser device (CA, USA) in a specialized light and laser clinic, with an output power of 300 mW with energy density of 2.5 J / cm2, in direct contact technique to the TMJ area for 20 seconds , Twice a week for 4 weeks.The groups will be evaluated in terms of pain intensity, rate of mouth opening, deviation during mouth opening and clicking sound.
-
Participants/Inclusion and exclusion criteria
-
Intrusion criteria:
limited mouth opening or function
presence of pain in masticatory muscles and/or TMJs, either in clenching or in jaw movements (TMD muscular disturbance or arthralgia.
Exclusion criteria:
patients who had major systemic disorders
patients who received analgesic or anti-depressant over the last 2 weeks
patients who had any bony abnormalities of the jaws such as arthropathy of the TMJ or rheumatoid arthritis
Patients with psychological illness
patients who received any form of treatment for TMD within the last month
pregnant and feeding patients.
-
Intervention groups
-
Intervention group: This group will be exposed to 940 nm laser with a power of 300 mW and to the temporomandibular joint area for 20 seconds two sessions per week for four weeks. In the same way, the placebo group will be exposed to Palsbo laser (device with laser off).
-
Main outcome variables
-
Patient satisfaction,Intensity of pain,The amount of mouth opening,Clicking sound,Deviation when opening the mouth